This report just reinforces why the share price is where its at.
AT 1 JULY 2011
Accumulated loss: (2,732,087)
AT 30 JUNE 2012
Accumulated loss: (7,835,219)
AT 30 JUNE 2013
Accumulated loss: (23,362,757)
PROFIT/(LOSS) AFTER RELATED INCOME TAX EXPENSE
(7,835,219) 2013 (2,732,087) 2012
TOTAL COMPREHENSIVE INCOME
(3,199,099) 2013 (2,179,762) 2012
- Forums
- ASX - By Stock
- PV1
- Ann: TTE 2013 Annual Report
Ann: TTE 2013 Annual Report , page-2
-
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PV1 (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $18.83M |
Open | High | Low | Value | Volume |
3.1¢ | 3.1¢ | 3.0¢ | $2.815K | 92.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 173452 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.1¢ | 63360 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 173452 | 0.030 |
2 | 58000 | 0.029 |
2 | 135714 | 0.028 |
6 | 238541 | 0.027 |
4 | 241475 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.031 | 63360 | 2 |
0.034 | 43994 | 2 |
0.035 | 66000 | 2 |
0.038 | 68445 | 3 |
0.039 | 15000 | 1 |
Last trade - 11.18am 16/07/2024 (20 minute delay) ? |
Featured News
PV1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online